Immune therapy and targeted therapy in urothelial cancer
Poster Session 73
-
Location:Room Amsterdam, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session Not all patients respond to BCG therapy for urothelium tumours. Immunological mechanisms relevant to a possible improvement of BCG treatment will be discussed in this session. In addition, novel functions of growth factors which are highly expressed in bladder cancer will be presented.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1Brighton and Sussex Medical School, Dept. of Urology, Brighton, United Kingdom, 2Brighton and Sussex Medical School, Division of Medicine, Brighton, United Kingdom, 3Brighton and Sussex University Hospitals, Dept. of Urology, Brighton, United Kingdom, 4Brighton and Sussex University Hospitals, Division of Medicine, Brighton, United Kingdom
Institutes: 1Coimbra University Hospital (CHUC), Urology and Renal Transplantation, Coimbra, Portugal, 2University of Coimbra – Faculty of Medicine, Institute For Biomedical Imaging and Life Sciences (IBILI), Coimbra, Portugal, 3University of Coimbra – Faculty of Medicine, Institute of Immunology, Coimbra, Portugal, 4University of Coimbra – Faculty of Medicine, Institute of Anatomical and Molecular Pathology, Coimbra, Portugal, 5University of Zurich, Viral Immunobiology, Institute of Experimental Immunology, Zurich, Switzerland, 6University of Coimbra – Faculty of Medicine, Laboratory of Pharmacology and Experimental Therapeutics, Institute For Biomedical Imaging and Life Sciences (IBILI), Coimbra, Portugal, 7University of Coimbra – Center For Neurosciences and Cell Biology (CNC), Immunology and Oncology Laboratory, Coimbra, Portugal
Institutes: 1Kyusyu University, Dept. of Urology, Fukuoka, Japan, 2The Vancouver Prostate Centre, Dept. of Urologic Sciences, University of British Columbia, Vancouver, Canada
Institutes: 1Hiroshima University, Dept. of Urology, Hiroshima, Japan, 2Vancouver Prostate Centre, Dept. of Urology, Vancouver, Canada
Institutes: 1Nagasaki University Graduate School of Biomedical Sciences, Dept. of Urology, Nagasaki, Japan, 2Nagasaki University Hospital, Dept. of Pathology, Nagasaki, Japan
Institutes: 1University of Rochester, Dept. of Pathology, Urology and Oncology, Rochester, United States of America, 2Johns Hopkins University, Dept. of Pathology and Urology, Baltimore, United States of America, 3University of Rochester, Dept. of Pathology and Oncology, Rochester, United States of America, 4Kyushu University, Dept. of Urology, Fukuoka, Japan, 5Yokohama City University Medical Center, Dept. of Urology and Renal Transplantation, Yokohama, Japan